細胞療法バイオ製造の世界市場は、2023年に約87億米ドルと評価され、2024年から2032年の予測期間中に11.5%の健全な年間複合成長率（CAGR）で成長し、2032年までに231億7,000万米ドルに達すると予想されています。
細胞療法バイオ製造は、治療用途の生細胞の製造、増殖、改変を伴う複雑なプロセスです。これらのプロセスは、損傷した組織の修復または置換、臓器の再生、または病気と闘うための免疫システムの強化を目的とした治療法の開発に極めて重要です。これらの治療法の用途は多岐にわたり、CAR-T細胞によるがん免疫療法、幹細胞療法による再生医療、遺伝性疾患の治療などの分野を網羅しています。慢性疾患の世界的な蔓延とバイオテクノロジーの絶え間ない進歩により、細胞療法バイオ製造の需要が高まっています。さらに、政府および民間部門の投資の急増により、これらの治療法の開発と拡張性が強化され、パーソナライズされた高度な治療がより利用しやすくなっています。
市場の成長は、がん、心血管疾患、自己免疫疾患などの慢性疾患の発症率の上昇に支えられています。細胞を改変または操作して疾患を治療または治癒する細胞療法は、従来の治療法では管理が難しい疾患に対する有望な解決策として浮上しています。これらの疾患の負担が世界的に増大するにつれて、革新的な治療ソリューションに対する需要がそれに応じて増加し、細胞療法のバイオ製造活動が大幅に増加しています。さらに、バイオテクノロジー、特に遺伝子編集と幹細胞研究の進歩は、細胞療法の状況に革命をもたらしています。CRISPR-Cas9などの技術により、正確な遺伝子改変が可能になり、細胞療法の有効性が向上しました。さらに、自動化やバイオプロセス技術などのバイオ製造プロセスの改善により、細胞療法の生産の効率と拡張性が向上し、高まる需要への対応に役立っています。
世界の細胞療法バイオ製造市場は、個別化医療への移行など、さまざまな機会により、大幅な成長が見込まれています。個々の遺伝子プロファイルに合わせた個別化細胞療法は、より効果的な治療成果を約束するため、高度なバイオ製造能力の必要性が高まっています。さらに、新興市場では、これらの地域で高度な医療技術が急速に導入され、医療インフラが拡大しているため、大きな成長の機会が生まれています。ただし、市場は課題に直面しており、特に細胞療法の製造に関連する高コストが課題となっています。複雑で労働集約的なプロセスと、特殊な機器や施設の必要性が、高額な費用の原因となり、アクセスと広範な導入が制限される可能性があります。品質と有効性を維持しながらこれらのコストの課題に対処することが、市場の長期的な成功にとって重要です。
世界の細胞療法バイオ製造市場調査で検討されている主要な地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。北アメリカは、活発な研究開発活動、確立された医療インフラ、バイオテクノロジーへの政府および民間セクターの多額の投資により、2023年に市場を支配しました。ヨーロッパも、先進的な治療法の採用の増加と支援的な規制枠組みにより、大きな市場シェアを占めています。アジア太平洋地域は、医療インフラへの投資の増加、先進的な医療治療の需要の高まり、慢性疾患の蔓延の増加により、予測期間中に最も速い成長が見込まれています。
目次
Table of Contents
Chapter 1. Global Cell Therapy Biomanufacturing Market Executive Summary
1.1. Global Cell Therapy Biomanufacturing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Cell Type
1.3.3. By Process
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Cell Therapy Biomanufacturing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Cell Therapy Biomanufacturing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Diseases
3.1.2. Advancements in Biotechnology
3.1.3. Government and Private Sector Investments
3.2. Market Challenges
3.2.1. High Manufacturing Costs
3.3. Market Opportunities
3.3.1. Personalized Medicine
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Cell Therapy Biomanufacturing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Cell Therapy Biomanufacturing Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Consumables
5.2.2. Equipment
5.2.3. Systems & Software
Chapter 6. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Cell Type 2022-2032
6.1. Segment Dashboard
6.2. Global Cell Therapy Biomanufacturing Market: Cell Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. T-cell
6.2.2. Stem Cell
6.2.3. Other Cell
Chapter 7. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Process 2022-2032
7.1. Segment Dashboard
7.2. Global Cell Therapy Biomanufacturing Market: Process Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Cell Processing
7.2.2. Cell Preservation, Distribution, and Handling
7.2.3. Process Monitoring and Quality Control
Chapter 8. Global Cell Therapy Biomanufacturing Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global Cell Therapy Biomanufacturing Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Biopharmaceutical & Biotechnology Companies and CROs
8.2.2. Research Institutes and Cell Banks
Chapter 9. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Region 2022-2032
9.1. North America Cell Therapy Biomanufacturing Market
9.1.1. U.S. Cell Therapy Biomanufacturing Market
9.1.1.1. Product Type breakdown size & forecasts, 2022-2032
9.1.1.2. Cell Type breakdown size & forecasts, 2022-2032
9.1.1.3. Process breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Cell Therapy Biomanufacturing Market
9.2. Europe Cell Therapy Biomanufacturing Market
9.2.1. U.K. Cell Therapy Biomanufacturing Market
9.2.2. Germany Cell Therapy Biomanufacturing Market
9.2.3. France Cell Therapy Biomanufacturing Market
9.2.4. Spain Cell Therapy Biomanufacturing Market
9.2.5. Italy Cell Therapy Biomanufacturing Market
9.2.6. Rest of Europe Cell Therapy Biomanufacturing Market
9.3. Asia-Pacific Cell Therapy Biomanufacturing Market
9.3.1. China Cell Therapy Biomanufacturing Market
9.3.2. India Cell Therapy Biomanufacturing Market
9.3.3. Japan Cell Therapy Biomanufacturing Market
9.3.4. Australia Cell Therapy Biomanufacturing Market
9.3.5. South Korea Cell Therapy Biomanufacturing Market
9.3.6. Rest of Asia Pacific Cell Therapy Biomanufacturing Market
9.4. Latin America Cell Therapy Biomanufacturing Market
9.4.1. Brazil Cell Therapy Biomanufacturing Market
9.4.2. Mexico Cell Therapy Biomanufacturing Market
9.4.3. Rest of Latin America Cell Therapy Biomanufacturing Market
9.5. Middle East & Africa Cell Therapy Biomanufacturing Market
9.5.1. Saudi Arabia Cell Therapy Biomanufacturing Market
9.5.2. South Africa Cell Therapy Biomanufacturing Market
9.5.3. Rest of Middle East & Africa Cell Therapy Biomanufacturing Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. MaxCyte (US)
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Thermo Fisher Scientific Inc. (US)
10.3.3. L7 Informatics, Inc. (US)
10.3.4. MAK-SYSTEM (US)
10.3.5. SIRION Biotech GmbH (Germany)
10.3.6. Fresenius Medical Care AG & Co. KGaA (Germany)
10.3.7. Sartorius AG (Germany)
10.3.8. STEMCELL Technologies (Canada)
10.3.9. Werum IT Solutions GmbH (Germany)
10.3.10. Terumo BCT (US)
10.3.11. Corning Incorporated (US)
10.3.12. OrganaBio, LLC (US)
10.3.13. Merck KGaA (Germany)
10.3.14. Becton, Dickinson and Company (US)
10.3.15. Miltenyi Biotec GmbH (Germany)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Cell Therapy Biomanufacturing market, report scope
TABLE 2. Global Cell Therapy Biomanufacturing market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Cell Therapy Biomanufacturing market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 4. Global Cell Therapy Biomanufacturing market estimates & forecasts by Cell Type 2022-2032 (USD Billion)
TABLE 5. Global Cell Therapy Biomanufacturing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Cell Therapy Biomanufacturing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Cell Therapy Biomanufacturing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Cell Therapy Biomanufacturing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Cell Therapy Biomanufacturing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Cell Therapy Biomanufacturing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Cell Therapy Biomanufacturing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Cell Therapy Biomanufacturing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Cell Therapy Biomanufacturing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Cell Therapy Biomanufacturing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Cell Therapy Biomanufacturing market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Cell Therapy Biomanufacturing market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Cell Therapy Biomanufacturing market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Cell Therapy Biomanufacturing market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Cell Therapy Biomanufacturing market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Cell Therapy Biomanufacturing market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete; the final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Cell Therapy Biomanufacturing market, research methodology
FIG 2. Global Cell Therapy Biomanufacturing market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cell Therapy Biomanufacturing market, key trends 2023
FIG 5. Global Cell Therapy Biomanufacturing market, growth prospects 2022-2032
FIG 6. Global Cell Therapy Biomanufacturing market, porters 5 force model
FIG 7. Global Cell Therapy Biomanufacturing market, PESTEL analysis
FIG 8. Global Cell Therapy Biomanufacturing market, value chain analysis
FIG 9. Global Cell Therapy Biomanufacturing market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Cell Therapy Biomanufacturing market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Cell Therapy Biomanufacturing market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Cell Therapy Biomanufacturing market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Cell Therapy Biomanufacturing market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Cell Therapy Biomanufacturing market, regional snapshot 2022 & 2032
FIG 15. North America Cell Therapy Biomanufacturing market 2022 & 2032 (USD Billion)
FIG 16. Europe Cell Therapy Biomanufacturing market 2022 & 2032 (USD Billion)
FIG 17. Asia-Pacific Cell Therapy Biomanufacturing market 2022 & 2032 (USD Billion)
FIG 18. Latin America Cell Therapy Biomanufacturing market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Cell Therapy Biomanufacturing market 2022 & 2032 (USD Billion)
FIG 20. Global Cell Therapy Biomanufacturing market, company market share analysis (2023)
…..
This list is not complete; the final report does contain more than 50 figures. The list may be updated in the final deliverable.
